State of availability of lymphedema physiotherapy services worldwide

Caroline M. Speksnijder, Jean Muzembo Ndundu, Nele Adriaenssens, Akinori Sato
Session outline:

Introduction (5 mins)

  • Overview of lymphedema physiotherapy services globally, based on a recent, international survey.
  • Importance of addressing CDT/CPT, cancer-related, and filarias-related lymphedema.


Case Studies and Evidence-Based Approaches (20 mins)

  • Presentation of diverse case studies showcasing effective CDT and physical therapy interventions.
  • Discussion on outcomes and challenges faced in different regions, emphasizing global disparities and successes.


Interdisciplinary Collaboration (15 mins)

  • Panel discussion with the lymphology experts in different domains (oncology, and infectious diseases) and continents around the globe (Europe and Central Africa, and we are aiming for an Asian partner for the seminar as well).
  • Insights into successful interdisciplinary models and their impact on lymphedema management.


Patient Perspectives (10 mins)

  • Video testimonials from patients highlighting their experiences with lymphedema treatment.
  • Discussion on incorporating patient-centered care into clinical practice.


Q&A and Interactive Session (10 mins)

  • Engagement with the audience to address specific clinical scenarios and practical challenges.
  • Exchange of ideas on implementing learnings in varied healthcare settings globally.
Diversity:

Our seminar ensures diversity through a multinational panel representing Europe and Central Africa (and hopefully Asia), fostering a rich exchange of perspectives. We prioritise gender balance and include voices from low, middle, and high-income countries, ensuring varied socio-economic viewpoints. Patient testimonials provide insights into underrepresented perspectives, enhancing the session's relevance and inclusivity. This approach aligns with World Physiotherapy's advocacy for diverse representation and international collaboration in advancing physiotherapy practice globally.




Learning objective 1:
Optimize lymphedema care in diverse healthcare settings, ensuring relevance across varying socio-economic contexts.
Learning objective 2:
Evaluate evidence-based strategies for treating cancer-related and filarias-related lymphedema, considering global variations.
Learning objective 3:
The importance of interdisciplinary/-cultural collaboration in optimizing lymphedema care, with focus on oncology, infectious diseases, and physiotherapy.
Bursary programme:
Yes
Approval:
yes
Attendance:
yes
Specialty group(s) contributing to this proposal:
["International Oncology, Palliative Care, and HIV/AIDS Physical Therapy Association","International Physical Therapists for HIV/AIDS, Oncology, Hospice and Palliative Care"]
Primary topic:
Oncology, HIV and palliative care
Second topic:
Globalisation: health systems, policies and strategies
Third topic:
Professional issues: diversity and inclusion
References/resources:

1. Wong HCY, Wallen MP, Chan AW, Dick N, Bonomo P, Bareham M, Wolf JR, van den Hurk C, Fitch M, Chow E, Chan RJ; MASCC BCRAL Expert Panel and the Oncodermatology and Survivorship Study Groups. Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidance for the prevention of breast cancer-related arm lymphoedema (BCRAL): international Delphi consensus-based recommendations. EClinicalMedicine. 2024 Feb 2;68:102441. doi: 10.1016/j.eclinm.2024.102441. PMID: 38333542; PMCID: PMC10850412.

 

2. Adriaenssens N, Overview of worldwide lymphedema care by physiotherapists based on an international survey. 29th ISL Word Congress of Lymphology; September 11-15, 2023, Magazzini del Cotone, Genova, Italy.

 

3. Martínez-Jaimez P, Fuster Linares P, Piller N, Masia J, Yamamoto T, López-Montoya L, Monforte-Royo C. Multidisciplinary preventive intervention for breast cancer-related lymphedema: An international consensus. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13704. doi: 10.1111/ecc.13704. Epub 2022 Sep 16. PMID: 36113999.

 

4. Moffatt CJ, Burian E, Karlsmark T, Keeley V, Vignes S, Doiron S, Tilley A, Liebl M, Reißhauer A, Murray S, Sykorova M, Quéré I, Franks PJ. Factors Predicting Limb Volume Reduction Using Compression Bandaging Within Decongestive Lymphatic Therapy in Lymphedema: A Multicountry Prospective Study. Lymphat Res Biol. 2021 Oct;19(5):412-422. doi: 10.1089/lrb.2021.0060. PMID: 34672790.

 

5. Tuğral A, Eliiyi U, Özdemir K, Ergin G, Bakar Y. A new era of seeking knowledge for #lymphedema on social media: A detailed Instagram hashtag analysis. Lymphology. 2021;54(2):68-77. PMID: 34735752.

 

6. Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peri­pheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lympholo­gy. 2020;53(1):3-19. 

 

7. Anwar SL, Adistyawan G, Wulaningsih W, Gutenbrunner C, Nugraha B. Rehabilitation for Cancer Survivors: How We Can Reduce the Healthcare Service Inequality in Low- and Middle-Income Countries. Am J Phys Med Rehabil. 2018 Oct;97(10):764-771. doi: 10.1097/PHM.0000000000000982. PMID: 29905600.

 

8. Schulze H, Nacke M, Gutenbrunner C, Hadamitzky C. Worldwide assessment of healthcare personnel dealing with lymphoedema. Health Econ Rev. 2018 Apr 16;8(1):10. doi: 10.1186/s13561-018-0194-6. PMID: 29663122; PMCID: PMC5901432.

 

9. Stout NL, Weiss R, Feldman JL, Stewart BR, Armer JM, Cormier JN, Shih YC. A systematic review of care delivery models and economic analyses in lymphedema: health policy impact (2004-2011). Lymphology. 2013 Mar;46(1):27-41. PMID: 23930439.

 

10. Stout NL, Brantus P, Moffatt C. Lymphoedema management: an international intersect between developed and developing countries. Similarities, differences and challenges. Glob Public Health. 2012;7(2):107-23. doi: 10.1080/17441692.2010.549140. Epub 2011 May 24. PMID: 21360379.



Funding acknowledgements:
no funding acknowledgements to declare
Terms and conditions:
yes

Back to the listing